upcoming glp-1 drugs What is the pipeline for future medications for obesity? Comparing Ozempic, Wegovy and Other

Description

If youre familiar with GLP-1s and dont need a lot of support or consultations, PlushCare could offer significant savings

Despite their benefits, GLP-1 medications present unique challenges at a national level

Effectiveness depends not only on the weight loss drugs, but also on consistent dosing and lifestyle efforts

cardiovascular death, nonfatal myocardial infarct, nonfatal stroke) for the GLP-1RA albiglutide, efpeglenatide, dulaglutide, liraglutide, and semaglutide ( The GLP-1RA liraglutide has also been approved for the treatment of obesity at a higher standard dose (3 mg once daily) compared to the standard dose used for T2D treatment (1.2 mg once daily) due to the results of the SCALE study program (37, 38)